Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
132.57B
Market cap132.57B
Price-Earnings ratio
27.92
Price-Earnings ratio27.92
Dividend yield
2.73%
Dividend yield2.73%
Average volume
10.15M
Average volume10.15M
High today
$105.72
High today$105.72
Low today
$103.26
Low today$103.26
Open price
$104.93
Open price$104.93
Volume
6.67M
Volume6.67M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$79.29
52 Week low$79.29

Stock Snapshot

As of today, Medtronic(MDT) shares are valued at $103.62. The company's market cap stands at 132.57B, with a P/E ratio of 27.92 and a dividend yield of 2.7%.

On 2025-12-02, Medtronic(MDT) stock moved within a range of $103.26 to $105.72. With shares now at $103.62, the stock is trading +0.3% above its intraday low and -2.0% below the session's peak.

Trading volume for Medtronic(MDT) stock has reached 6.67M, versus its average volume of 10.15M.

Over the past 52 weeks, Medtronic(MDT) stock has traded between a high of $106.33 and a low of $79.29.

Over the past 52 weeks, Medtronic(MDT) stock has traded between a high of $106.33 and a low of $79.29.

MDT News

Simply Wall St 2d
A Look at Medtronic’s Valuation After Strong Earnings and Raised Guidance

Medtronic (NYSE:MDT) just posted financial results that outpaced last year in both revenue and earnings, giving investors something to talk about. The company a...

A Look at Medtronic’s Valuation After Strong Earnings and Raised Guidance
Simply Wall St 5d
Medtronic Net Margin Improves to 13.7%, Reinforcing Profitability Narrative

Medtronic (MDT) just posted its Q2 2026 numbers, reporting revenue of $9.0 billion and EPS of $1.07. Looking back, the company has seen revenue rise from $8.4 b...

Medtronic Net Margin Improves to 13.7%, Reinforcing Profitability Narrative
Simply Wall St 6d
Did Medtronic's Raised Guidance and Acquisition Focus Just Reshape Its Investment Narrative?

On November 18, 2025, Medtronic plc raised its earnings and revenue guidance for fiscal years 2026 and 2027, following stronger-than-expected quarterly sales an...

Did Medtronic's Raised Guidance and Acquisition Focus Just Reshape Its Investment Narrative?

Analyst ratings

50%

of 34 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.